Brief: Finch Therapeutics Receives Nasdaq Notice
06/01/2023 13:20
Jan 6 (Reuters) - Finch Therapeutics Group Inc FNCH.O :
* FINCH THERAPEUTICS GROUP INC - ON DEC 30, RECEIVED FROM
NASDAQ
NOTICE OF DELISTING OR FAILURE TO SATISFY CONTINUED LISTING RULE
OR STANDARD
Source text for Eikon: ID:
Further company coverage: FNCH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Finch Therapeutics
See all newsFinch wins US jury trial against Ferring over fecal-transplant patents
Brief: Finch Therapeutics Group Received A Notice From Nasdaq Acknowledging Fact That Co Does Not Meet Requirements Of Rules On April 2
Brief: Finch Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq’s Listing Rule 5450(A)(1)
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
U.S. STOCKS ON THE MOVE-Teekay, gold miners, Oil-Dri Corp